|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ezeh UI, Turek PJ, Reijo RA and Clark AT:
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are
expressed in both seminoma and breast carcinoma. Cancer.
104:2255–2265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Amini S, Fathi F, Mobalegi J,
Sofimajidpour H and Ghadimi T: The expressions of stem cell
markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3,
Dppa4, and Esrrb in bladder, colon, and prostate cancer, and
certain cancer cell lines. Anat Cell Biol. 47:1–11. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du J, Chen T, Zou X, Xiong B and Lu G:
Dppa2 knockdown-induced differentiation and repressed proliferation
of mouse embryonic stem cells. J Biochem. 147:265–271. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang M, Cui F, Lu S, Lu H, Xue Y, Wang J,
Chen J, Zhao S, Ma S, Zhang Y, et al: Developmental
pluripotency-associated 4: A novel predictor for prognosis and a
potential therapeutic target for colon cancer. J Exp Clin Cancer
Res. 34:602015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tung PY, Varlakhanova NV and Knoepfler PS:
Identification of DPPA4 and DPPA2 as a novel family of
pluripotency-related oncogenes. Stem Cells. 31:2330–2342. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang Y, Xiao J, Zhao S, Feng Y and Zhang
H: A study on construction of plasmid pcDNA3.1 (−) CMV.CD and
transfection into laryngeal cancer cell Hep-2. Lin Chuang Er Bi Yan
Hou Ke Za Zhi. 19:988–991. 2005.(In Chinese). PubMed/NCBI
|
|
9
|
Peirson SN, Butler JN and Foster RG:
Experimental validation of novel and conventional approaches to
quantitative real-time PCR data analysis. Nucleic Acids Res.
31:e732003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chakravarthy H, Boer B, Desler M, Mallanna
SK, McKeithan TW and Rizzino A: Identification of DPPA4 and other
genes as putative Sox2:Oct-3/4 target genes using a combination of
in silico analysis and transcription-based assays. J Cell Physiol.
216:651–662. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abdul Khalek FJ, Gallicano GI and Mishra
L: Colon cancer stem cells. Gastrointest Cancer Res. (Suppl
1):S16–S23. 2010.PubMed/NCBI
|
|
13
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:5042008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jones CL, Stevens BM, D'Alessandro A,
Reisz JA, Culp-Hill R, Nemkov T, Pei S, Khan N, Adane B, Ye H, et
al: Inhibition of amino acid metabolism selectively targets human
leukemia stem cells. Cancer Cell. 34:724–740.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu J, Tan M and Cai Q: The Warburg effect
in tumor progression: Mitochondrial oxidative metabolism as an
anti-metastasis mechanism. Cancer Lett. 356:156–164. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin L, Huang H, Liao W, Ma H, Liu J, Wang
L, Huang N and Liao Y: MACC1 supports human gastric cancer growth
under metabolic stress by enhancing the Warburg effect. Oncogene.
34:2700–2710. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Christofk HR, Vander Heiden MG, Wu N,
Asara JM and Cantley LC: Pyruvate kinase M2 is a
phosphotyrosine-binding protein. Nature. 452:181–186. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mathupala SP, Heese C and Pedersen PL:
Glucose catabolism in cancer cells. The type II hexokinase promoter
contains functionally active response elements for the tumor
suppressor p53. J Biol Chem. 272:22776–22780. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoshikawa T, Noguchi Y and Satoh S:
Inhibition of IRS-1 phosphorylation and the alterations of GLUT4 in
isolated adipocytes from cachectic tumor-bearing rats. Biochem
Biophys Res Commun. 256:676–681. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leiblich A, Cross SS, Catto JW, Phillips
JT, Leung HY, Hamdy FC and Rehman I: Lactate dehydrogenase-B is
silenced by promoter hypermethylation in human prostate cancer.
Oncogene. 25:2953–2960. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song T, Gan W, Chen J, Huang L, Yin H, He
T, Huang H and Hu X: Antibodies against Clonorchis sinensis LDH
could cross-react with LDHB localizing on the plasma membrane of
human hepatocarcinoma cell SMMC-7721 and induce apoptosis.
Parasitol Res. 115:1595–1603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McCleland ML, Adler AS, Deming L, Cosino
E, Lee L, Blackwood EM, Solon M, Tao J, Li L, Shames D, et al:
Lactate dehydrogenase B is required for the growth of
KRAS-dependent lung adenocarcinomas. Clin Cancer Res. 19:773–784.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCleland ML, Adler AS, Shang Y, Hunsaker
T, Truong T, Peterson D, Torres E, Li L, Haley B, Stephan JP, et
al: An integrated genomic screen identifies LDHB as an essential
gene for triple-negative breast cancer. Cancer Res. 72:5812–5823.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dennison JB, Molina JR, Mitra S,
González-Angulo AM, Balko JM, Kuba MG, Sanders ME, Pinto JA, Gómez
HL, Arteaga CL, et al: Lactate dehydrogenase B: A metabolic marker
of response to neoadjuvant chemotherapy in breast cancer. Clin
Cancer Res. 19:3703–3713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen R, Zhou X, Yu Z, Liu J and Huang G:
Low expression of LDHB correlates with unfavorable survival in
hepatocellular carcinoma: Strobe-compliant article. Medicine
(Baltimore). 94:e15832015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui J, Quan M, Jiang W, Hu H, Jiao F, Li
N, Jin Z, Wang L and Wang Y: Suppressed expression of LDHB promotes
pancreatic cancer progression via inducing glycolytic phenotype.
Med Oncol. 32:1432015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maekawa M, Taniguchi T, Ishikawa J,
Sugimura H, Sugano K and Kanno T: Promoter hypermethylation in
cancer silences LDHB, eliminating lactate dehydrogenase isoenzymes
1–4. Clin Chem. 49:1518–1520. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Revill K, Wang T, Lachenmayer A, Kojima K,
Harrington A, Li J, Hoshida Y, Llovet JM and Powers S: Genome-wide
methylation analysis and epigenetic unmasking identify tumor
suppressor genes in hepatocellular carcinoma. Gastroenterology.
145:1424–135.e1-e25. 2013. View Article : Google Scholar : PubMed/NCBI
|
